Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells
- PMID: 15315846
- DOI: 10.1016/j.vaccine.2004.03.024
Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells
Abstract
P20778, an Indian strain of Japanese encephalitis virus (JEV) obtained from Vellore in the Southern India, was grown in Vero cells cultured on microcarriers in a spinner flask. The virus was formalin-inactivated and its immunogenicity and protective efficacy in mice were tested in comparison with a commercially available vaccine. Our studies indicated that formalin-inactivated JEV P20778 induced high levels of protective immunity in mice. Virus inactivation with formalin at 22 degrees C, which required shorter incubation period, was found to be as good or better to virus inactivation at 4 degrees C for generating high titers of anti-JEV antibodies. Similarly, the 22 degrees C-inactivated virus generated JEV neutralizing antibody titers as good or higher than those induced by the 4 degrees C-inactivated virus. Thus, for the vaccine production, inactivation of JEV with formalin at 22 degrees C would be a preferred method as it is faster and does not require cold room storage.
Similar articles
-
Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.Vaccine. 2009 Oct 9;27(43):6004-10. doi: 10.1016/j.vaccine.2009.07.078. Epub 2009 Aug 7. Vaccine. 2009. PMID: 19665607
-
Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.J Gene Med. 2009 Feb;11(2):150-9. doi: 10.1002/jgm.1282. J Gene Med. 2009. Retraction in: J Gene Med. 2009 May;11(5):454. doi: 10.1002/jgm.1330. PMID: 19040206 Retracted.
-
Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.Virus Res. 2006 Nov;121(2):152-60. doi: 10.1016/j.virusres.2006.05.004. Epub 2006 Sep 1. Virus Res. 2006. PMID: 16815584
-
IC51 Japanese encephalitis vaccine.Expert Opin Biol Ther. 2009 Jul;9(7):921-31. doi: 10.1517/14712590903042282. Expert Opin Biol Ther. 2009. PMID: 19527110 Review.
-
Ixiaro: a new vaccine against Japanese encephalitis.Expert Rev Vaccines. 2009 Nov;8(11):1501-11. doi: 10.1586/erv.09.112. Expert Rev Vaccines. 2009. PMID: 19863241 Review.
Cited by
-
Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India.J Biosci. 2008 Nov;33(4):505-14. doi: 10.1007/s12038-008-0069-9. J Biosci. 2008. PMID: 19208976 Review.
-
Epidemiological concordance of Japanese encephalitis virus infection among mosquito vectors, amplifying hosts and humans in India.Epidemiol Infect. 2013 Jan;141(1):74-80. doi: 10.1017/S0950268812000258. Epub 2012 Feb 24. Epidemiol Infect. 2013. PMID: 22361257 Free PMC article.
-
Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III.PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004167. doi: 10.1371/journal.pntd.0004167. eCollection 2015 Oct. PLoS Negl Trop Dis. 2015. PMID: 26495991 Free PMC article.
-
Development of an inactivated candidate vaccine against Chandipura virus (Rhabdoviridae: Vesiculovirus).Vaccine. 2011 Jun 20;29(28):4613-7. doi: 10.1016/j.vaccine.2011.04.063. Epub 2011 May 5. Vaccine. 2011. PMID: 21549791 Free PMC article.
-
Japanese Encephalitis Virus Infected Human Monocyte-Derived Dendritic Cells Activate a Transcriptional Network Leading to an Antiviral Inflammatory Response.Front Immunol. 2021 Jun 17;12:638694. doi: 10.3389/fimmu.2021.638694. eCollection 2021. Front Immunol. 2021. PMID: 34220803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources